Skip to main content
BMJ Case Reports logoLink to BMJ Case Reports
. 2021 Aug 11;14(8):e244988. doi: 10.1136/bcr-2021-244988

Gianotti-Crosti syndrome: a frequent but underdiagnosed rash

Ivo Miguel Neves 1,, Maria Ventura Nogueira 1, Cláudia Patraquim 1, Manuela Costa Alves 1
PMCID: PMC8359529  PMID: 34380692

Description

We present the case of a healthy 2-year-old child, with irrelevant personal and family history, that was taken to the emergency department for a papulovesicular rash that has developed and evolved over 5 days. It started on the foot, subsequently reaching to the hands, face and remaining integument, with mild pruritus and without interfering with sleep. Concomitantly with the appearance of the lesions, she started fever, lasting 2 days and mentioned food refusal and nasopharyngitis prior to the onset of rash. No other symptoms were associated.

Physical examination showed a papulovesicular rash predominating in the extremities, legs and feet, buttocks and face (figure 1); some crusted lesions on palms (figure 2) and plants. Scalp, genital and anal mucosas were spared. No other major changes were found in the physical examination.

Figure 1.

Figure 1

Papulovesicular rash.

Figure 2.

Figure 2

Crusted lesions on palms.

Simple laboratory evaluation was performed and the results did not present major changes, only a slightly elevated sedimentation rate (25 mm/hour) and C reactive protein (7.9 mg/L). Serologies were negative for hepatitis B and C virus, HIV, Epstein-Barr virus (EBV) and Mycoplasma pneumoniae. Parvovirus B19-specific IgG antibodies were negative and IgM was doubtful. Human herpesvirus 6 (HHV-6) DNA was positive in the blood.

The definitive diagnosis of Gianotti-Crosti syndrome (GCS) by HHV-6 was made. This is a self-limited skin eruption, which usually occurs in children under 5 years of age and clinically manifests with papular/papulovesicular rash that may coalesce into plaques, usually in association with viral infections (most often EBV or hepatitis B virus infection), being HHV-6 an uncommon cause of GCS. Occasionally, it can occur in association with vaccination or bacterial infections.

The patients may also present extracutaneous signs and symptoms (eg, malaise, fever, diarrhoea, lymphadenopathy, hepatomegaly).

The diagnosis is clinic and there are no specific laboratory features characteristic of GCS; however, the laboratory tests to identify an aetiologic cause may also be considered in specific situations, for example, patients with extracutaneous clinical findings as in this case report.1 2

The prognosis of GCS is excellent; however, the rash may take time to resolve; it usually resolves spontaneously between 10 days and 6 months, thus, requiring no treatment.3

In case of pruritus, treatment is supportive through the use of emollients/topical antipruritic lotions (provides relief) and oral antihistamines (if the pruritus interferes with sleep and activities of daily living).4

It is important to recognise this entity in order to avoid carrying out complementary unnecessary tests for diagnoses.

Patient’s perspective.

We realised that the cutaneous symptoms were related to a viral infection and that the prognosis was excellent once it is a self-limited cutaneous disorder and the treatment is only symptomatic with pruritus control. We are grateful to the medical team for explaining it in simple words.

Learning points.

  • Gianotti-Crosti syndrome is a self-limited skin eruption and it is associated with viral infections (most frequent), vaccination or bacterial infections.

  • The diagnosis is clinic and the prognosis is excellent.

  • The treatment is supportive through the use of emollients/topical antipruritic lotions.

Footnotes

Contributors: IMN: cared for the patient, edited the manuscript, prepared the figures and obtained the written informed consent. MVN, CP and MCA: cared for the patient, edited the manuscript and gave useful discussions.

Funding: The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

Competing interests: None declared.

Provenance and peer review: Not commissioned; externally peer reviewed.

Ethics statements

Patient consent for publication

Parental/guardian consent obtained.

References

  • 1.Chuh AA. Gianotti-Crosti syndrome (papular acrodermatitis). UpToDate [Internet], 2019. Available: https://www.uptodate.com/contents/gianotti-crostisyndrome-papularacrodermatitis [Accessed Nov 2020].
  • 2.Nelson JS, Stone MS. Update on selected viral exanthems. Curr Opin Pediatr 2000;12:359–64. 10.1097/00008480-200008000-00014 [DOI] [PubMed] [Google Scholar]
  • 3.Chuh A, Lee A, Zawar V. The diagnostic criteria of gianotti-Crosti syndrome: are they applicable to children in India? Pediatr Dermatol 2004;21:542–7. 10.1111/j.0736-8046.2004.21503.x [DOI] [PubMed] [Google Scholar]
  • 4.Boeck K, Mempel M, Schmidt T, et al. Gianotti-Crosti syndrome: clinical, serologic, and therapeutic data from nine children. Cutis 1998;62:271-4; quiz 286. [PubMed] [Google Scholar]

Articles from BMJ Case Reports are provided here courtesy of BMJ Publishing Group

RESOURCES